Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
2
Mins
4 Jun 2015
The Last Frontier, Men’s Health
The 21st century is well upon us, and the scientific and health landscape is rapidly changing, yet there are still new horizons to conquer.
4 Jun 2015
Dr Kevin Campbell, Our #EMJExpert, Answers Your Questions for Heart Rhythm Week
In support of Heart Rhythm Week, an annual campaign designed to raise global awareness and understanding of arrhythmias, we invited world-renowned…
2 Jun 2015
Early-Stage Trial of Nivolumab in Advanced Liver Cancer
Findings from a phase I/II study suggest that nivolumab is safe and effective in advanced liver cancer. Based on the results of the phase I part of the…
2 Jun 2015
Genomic Marker Predicts Anti-PD-1 Response in Several Cancers
A phase II study identified the first genomic marker – mismatch repair (MMR) deficiency – to predict response to the anti-PD-1 antibody pembrolizumab…
2 Jun 2015
Pembrolizumab Shows Promising Activity Against Head and Neck Cancer
A 132-patient study indicates that pembrolizumab immunotherapy is effective for patients with recurrent or metastatic head and neck cancer (HNC). The…
2 Jun 2015
Nivolumab Extends Survival for Patients With the Most Common Lung Cancer
Findings from a randomised phase III study indicate that PD-1 immunotherapy is an effective treatment option for patients with non-squamous, non-small…
2 Jun 2015
An introduction to ASCO 2015 by the 2014-15 president, Peter Paul Yu, MD, FACP, FASCO
Peter Paul Yu, MD, FACP, FASCO introduces ASCO 2015 and the conference themes – how to utilise data, to transform it into learning to impact patient care.
1 Jun 2015
Mediterranean Diet for a Healthy Mind
MEDITERRANEAN diets, supplemented with additional portions of antioxidant-rich extra virgin olive oil or mixed nuts, could protect cognitive functioning…
1 Jun 2015
Head Transplants: No Longer Science Fiction But a Step Closer to Reality?
HUMAN head transplants have, until recently, been nothing more than science fiction, but Dr Sergio Canavero, Director of the Turin Advanced…
29 May 2015
All Forms of Smoking Are Bad for the Heart
Sophia Antipolis, 31 May 2015: All forms of smoking are bad for the heart, the European Society of Cardiology (ESC) warned today…
←
1
2
3
…
866
867
868
869
870
871
872
…
921
922
923
→